Pharmacogenomics of antithrombotic drugs –a novel study design and data collection approach using Finnish biobanks and national registries

Medicine and Dentistry

• Antithrombotic 100%
• Genotype 83%
• Combination Therapy 50%
• Study Design 50%
• Genetic Variability 33%
• Direct Oral Anticoagulant 33%
• Association 33%
• Aging 16%
• Heparin 16%
• Retrospective Cohort Study 16%
• Gold 16%
• Drug Response 16%
• Drug Therapy 16%
• Development 16%
• Drug 16%
• Warfarin 16%
• Pharmacogenetic Testing 16%
• Clopidogrel 16%
• Bleeding 16%
• Gene Linkage 16%
• Health 16%
• Comprehension 16%
• Laboratory 16%
• Therapeutic Procedure 16%
• Chemotherapeutic Agent 16%
• Adult 16%
• Incidence 16%

Biochemistry, Genetics and Molecular Biology

• Genotyping 83%
• Genetic Divergence 33%
• Association 33%
• Aging 16%
• Classification 16%
• Phenotype 16%
• Heparin 16%
• Data Base 16%
• Sample Size 16%
• Allele 16%
• Drug Response 16%
• Light 16%
• Development 16%
• Time 16%
• Health 16%
• Comprehension 16%
• Cohort Study 16%
• Incidence 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Pharmacogenomics 100%
• Antithrombotic Therapy 66%
• Gold 16%
• Heparin 16%
• Warfarin 16%
• Drug 16%
• Incidence 16%
• Clopidogrel 16%
• Bleeding 16%